Stab Therapeutics

STAb Therapeutics appoints Carolina Pola as Chief Executive Officer

Uncategorized /

STAb Therapeutics, a biotechnology company that develops novel immune redirecting cell therapies for cancer, announces that Dr. Carolina Pola has been appointed as CEO of the Company. Dr. Pola brings a biobusiness perspective and expertise to STAb Therapeutics to develop and deploy the strategic plan for the growth of the Company. She has developed an

STAb Therapeutics appoints Carolina Pola as Chief Executive Officer Leer más »

Granted by Consejería de Educación, Ciencia y Universidades

Awards /

STAb Therapeutics has been awarded with one of grants for the development of new innovative technology-based companies: “Ayudas para el desarrollo de nuevas empresas innovadoras de base tecnológica (start-up) (2023)”, granted by Consejería de Educación, Ciencia y Universidades, Comunidad Autónoma de Madrid. These grants are aimed at promoting the activity and consolidation of novel and

Granted by Consejería de Educación, Ciencia y Universidades Leer más »

Awarded by Fundación para el Conocimiento Madri+d

Awards /

STAb Therapeutics, spin-off from Instituto de Investigación Hospital 12 de Octubre i+12, has been awarded by the Fundación para el Conocimiento Madri+d, in the framework of the health entrepreneurship program ‘Healthstart’. This award is a recognition to the company´s viability plan, developed by scientists from this institution, to transfer the results obtained in their laboratory

Awarded by Fundación para el Conocimiento Madri+d Leer más »

Scroll al inicio